CD8A and neoplasm: Of note, Trm cells have been identified as members of CD8+ tumor infiltrating lymphocytes (TILs) in patients with various solid tumors, and a Trm cell gene signature has been associated with a favorable prognosis and an increased likelihood of a response to anti-PD1 therapy in lung, breast, and melanoma cancers (48).